Cargando…

Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)

Left heart disease is the main cause of clinical pulmonary arterial hypertension (PAH). Common types of left heart disease that result in PAH include heart failure, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and valvular disease. It is currently believed that mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wenfeng, Guo, Haixu, Xu, Jinrong, Cai, Shuyun, He, Yuan, Shui, Xiaorong, Huang, Shian, Luo, Hui, Lei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388838/
https://www.ncbi.nlm.nih.gov/pubmed/32582962
http://dx.doi.org/10.3892/ijmm.2020.4650
_version_ 1783564379824848896
author Ye, Wenfeng
Guo, Haixu
Xu, Jinrong
Cai, Shuyun
He, Yuan
Shui, Xiaorong
Huang, Shian
Luo, Hui
Lei, Wei
author_facet Ye, Wenfeng
Guo, Haixu
Xu, Jinrong
Cai, Shuyun
He, Yuan
Shui, Xiaorong
Huang, Shian
Luo, Hui
Lei, Wei
author_sort Ye, Wenfeng
collection PubMed
description Left heart disease is the main cause of clinical pulmonary arterial hypertension (PAH). Common types of left heart disease that result in PAH include heart failure, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and valvular disease. It is currently believed that mechanical pressure caused by high pulmonary venous pressure is the main cause of myocardial infarction (MI) in individuals with ischemic cardiomyopathy and left ventricular systolic dysfunction. In the presence of decreased cardiac function, vascular remodeling of pulmonary vessels in response to long-term stimulation by high pressure in turn leads to exacerbation of PAH. However, the underlying pathological mechanisms remain unclear. Elucidating the association between the development of MI and PAH may lead to a better understanding of potential risk factors and better disease treatment. In this article, the pathophysiological effects of multiple systems in individuals with MI and PAH were reviewed in order to provide a general perspective on various potential interactions between cardiomyocytes and pulmonary vascular cells.
format Online
Article
Text
id pubmed-7388838
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-73888382020-08-05 Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) Ye, Wenfeng Guo, Haixu Xu, Jinrong Cai, Shuyun He, Yuan Shui, Xiaorong Huang, Shian Luo, Hui Lei, Wei Int J Mol Med Articles Left heart disease is the main cause of clinical pulmonary arterial hypertension (PAH). Common types of left heart disease that result in PAH include heart failure, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and valvular disease. It is currently believed that mechanical pressure caused by high pulmonary venous pressure is the main cause of myocardial infarction (MI) in individuals with ischemic cardiomyopathy and left ventricular systolic dysfunction. In the presence of decreased cardiac function, vascular remodeling of pulmonary vessels in response to long-term stimulation by high pressure in turn leads to exacerbation of PAH. However, the underlying pathological mechanisms remain unclear. Elucidating the association between the development of MI and PAH may lead to a better understanding of potential risk factors and better disease treatment. In this article, the pathophysiological effects of multiple systems in individuals with MI and PAH were reviewed in order to provide a general perspective on various potential interactions between cardiomyocytes and pulmonary vascular cells. D.A. Spandidos 2020-09 2020-06-18 /pmc/articles/PMC7388838/ /pubmed/32582962 http://dx.doi.org/10.3892/ijmm.2020.4650 Text en Copyright: © Ye et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Ye, Wenfeng
Guo, Haixu
Xu, Jinrong
Cai, Shuyun
He, Yuan
Shui, Xiaorong
Huang, Shian
Luo, Hui
Lei, Wei
Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
title Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
title_full Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
title_fullStr Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
title_full_unstemmed Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
title_short Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
title_sort heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (review)
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388838/
https://www.ncbi.nlm.nih.gov/pubmed/32582962
http://dx.doi.org/10.3892/ijmm.2020.4650
work_keys_str_mv AT yewenfeng heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT guohaixu heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT xujinrong heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT caishuyun heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT heyuan heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT shuixiaorong heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT huangshian heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT luohui heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview
AT leiwei heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview